As local and international public health officials work to end the Ebola epidemic in West Africa, efforts to develop therapies and vaccines against the virus are ramping up. The ongoing epidemic has sparked an unprecedented level of multinational cooperation to speed clinical trials of potential therapeutics and vaccines. Several interventions for Ebola currently entering early-phase clinical trials were developed years ago, said UTMB’s Thomas Geisbert. But until the current large-scale, multicountry outbreak that began in 2013, there wasn’t a sense of urgency or much funding for clinical trials. “I’ve never seen anything like this,” said Geisbert. “It really was the outbreak that pushed things to the forefront.”